Rankings
▼
Calendar
PHAT Q4 2018 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
PHAT
Phathom Pharmaceuticals, Inc.
$831M
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$451,000
Net Income
-$484,000
EPS (Diluted)
$-0.06
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$302,000
Free Cash Flow
-$302,000
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$902,000
Total Liabilities
$2M
Stockholders' Equity
-$1M
Cash & Equivalents
$879,000
← FY 2018
All Quarters
Q1 2019 →
